Morrison Susan 4
4 · TANDEM DIABETES CARE INC · Filed Aug 19, 2025
Insider Transaction Report
Form 4
Morrison Susan
EVP & Chief Admin. Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-08-15−1,097→ 7,677 total→ Common Stock (1,097 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-08-15−1,503→ 4,509 total→ Common Stock (1,503 underlying) - Exercise/Conversion
Common Stock
2025-08-15+1,097→ 39,376 total - Tax Payment
Common Stock
2025-08-15$10.82/sh−430$4,653→ 38,279 total - Exercise/Conversion
Common Stock
2025-08-15+1,503→ 38,709 total - Tax Payment
Common Stock
2025-08-15$10.82/sh−314$3,397→ 39,062 total
Footnotes (6)
- [F1]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
- [F3]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F5]Awarded on May 23, 2024 pursuant to the 2023 Plan.
- [F6]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.